1. Home
  2. SISI vs AFMD Comparison

SISI vs AFMD Comparison

Compare SISI & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SISI
  • AFMD
  • Stock Information
  • Founded
  • SISI 1997
  • AFMD 2000
  • Country
  • SISI China
  • AFMD Germany
  • Employees
  • SISI N/A
  • AFMD N/A
  • Industry
  • SISI Medicinal Chemicals and Botanical Products
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • SISI Health Care
  • AFMD Health Care
  • Exchange
  • SISI Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • SISI 14.9M
  • AFMD 10.2M
  • IPO Year
  • SISI 2016
  • AFMD 2014
  • Fundamental
  • Price
  • SISI $0.80
  • AFMD $0.70
  • Analyst Decision
  • SISI
  • AFMD Strong Buy
  • Analyst Count
  • SISI 0
  • AFMD 5
  • Target Price
  • SISI N/A
  • AFMD $13.50
  • AVG Volume (30 Days)
  • SISI 603.5K
  • AFMD 120.2K
  • Earning Date
  • SISI 05-19-2025
  • AFMD 06-11-2025
  • Dividend Yield
  • SISI N/A
  • AFMD N/A
  • EPS Growth
  • SISI N/A
  • AFMD N/A
  • EPS
  • SISI N/A
  • AFMD N/A
  • Revenue
  • SISI $11,072,553.00
  • AFMD $6,287,085.00
  • Revenue This Year
  • SISI N/A
  • AFMD N/A
  • Revenue Next Year
  • SISI N/A
  • AFMD $225.65
  • P/E Ratio
  • SISI N/A
  • AFMD N/A
  • Revenue Growth
  • SISI 145.88
  • AFMD N/A
  • 52 Week Low
  • SISI $0.39
  • AFMD $0.52
  • 52 Week High
  • SISI $117.65
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • SISI 47.99
  • AFMD 40.82
  • Support Level
  • SISI $0.39
  • AFMD $0.91
  • Resistance Level
  • SISI $0.90
  • AFMD $1.13
  • Average True Range (ATR)
  • SISI 0.18
  • AFMD 0.09
  • MACD
  • SISI 0.01
  • AFMD -0.01
  • Stochastic Oscillator
  • SISI 54.30
  • AFMD 4.68

About SISI Shineco Inc.

Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: